For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are ...

Surgically ligating the left atrial appendage (LAA) during implantation of the HeartMate 3 left ventricular assist device (LVAD; Abbott) does not affect survival or hemocompatibility-related adverse ...

Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial fibrilla ...

For patients with nonvalvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use ...

MIDLAND, Texas (KMID/KPEJ) – Midland Memorial Health is now offering a new procedure called Left Atrial Appendage Occlusion.

Please provide your email address to receive an email when new articles are posted on . Outcomes for ablation of persistent AF by pulmonary vein antral isolation (PVAI) alone have been historically ...

Left atrial appendage occlusion is a generally safe and effective procedure to lower the risk of stroke in people with atrial fibrillation. It closes or blocks off the left atrial appendage of the ...

Atrial fibrillation treatment with device closure matched anticoagulants and reduced bleeding risk. Discover what this means for AF care.

WASHINGTON (March 19, 2017) -- For patients with atrial fibrillation (AFib), a common heart rhythm disorder, closing the area of the heart known as the left atrial appendage as an add-on procedure ...

Loyola Medicine is enrolling patients in a landmark clinical trial of a new procedure to treat atrial fibrillation, the most common type of irregular heartbeat. The clinical trial will combine the ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...